Sunshine Biopharma (SBFMW) Non Operating Investment Income (2014 - 2015)
Sunshine Biopharma (SBFMW) reported Non Operating Investment Income of -$513155.0 for Q2 2015, up 32.97% on a YoY basis from -$385929.9 in Q2 2014, and up 32.97% quarter-over-quarter from -$765513.0 in Q2 2014.
Sunshine Biopharma (SBFMW) Non Operating Investment Income (2014 - 2015) Analysis & Trends
Sunshine Biopharma has reported Non Operating Investment Income for 2 years, with the latest figure at -$513155.0 in Q2 2015.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non Operating Investment Income (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 39.97 Bn | 36.23 Bn | 1.97 Bn | - |
| 2 | Zoetis | 33.59 Bn | 31.65 Bn | 1.62 Bn | - |
| 3 | United Therapeutics | 23.75 Bn | 21.60 Bn | 648.10 Mn | - |
| 4 | Neurocrine Biosciences | 16.10 Bn | 14.78 Bn | 800.70 Mn | - |
| 5 | Aurora Cannabis | 15.56 Bn | 15.47 Bn | 21.72 Mn | - |
| 6 | Elanco Animal Health | 12.04 Bn | 11.61 Bn | 785.00 Mn | - |
| 7 | Alkermes | 7.36 Bn | 6.84 Bn | -116.06 Mn | - |
| 8 | Lantheus Holdings | 6.74 Bn | 6.24 Bn | 230.92 Mn | - |
| 9 | Liquidia | 6.27 Bn | 6.04 Bn | 121.79 Mn | - |
| 10 | Sunshine Biopharma | - | - | 2.18 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2015 | -513,155.00 |
| Jun 30, 2015 | -513,155.00 |
| Jun 30, 2014 | -765,513.00 |
| Jun 30, 2014 | -765,513.00 |